Home/Filings/4/0001415889-17-001795
4//SEC Filing

Weisman Susan 4

Accession 0001415889-17-001795

CIK 0000075439other

Filed

Nov 15, 7:00 PM ET

Accepted

Nov 16, 12:31 PM ET

Size

4.8 KB

Accession

0001415889-17-001795

Insider Transaction Report

Form 4
Period: 2017-04-26
Weisman Susan
CHIEF FINANCIAL OFFICER
Transactions
  • Award

    Common Stock

    2017-04-26$0.81/sh+200,000$162,000200,000 total

Issuer

Medite Cancer Diagnostics, Inc.

CIK 0000075439

Entity typeother

Related Parties

1
  • filerCIK 0001325784

Filing Metadata

Form type
4
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 12:31 PM ET
Size
4.8 KB